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The need to educate patients in order to enable them to
participate in making appropriate choices for all therapeutic
options in end stage renal disease would seem obvious yet
there are many barriers to providing such information. We
measured ‘perceived knowledge’ of the therapeutic options
for end stage renal disease in a cohort of patients with
chronic kidney disease in established treatment programs.
A self administered questionnaire was given to 676 patients
with stage 3–5 chronic kidney disease as part of the CRIOS
study designed to identify trends in practice patterns and
outcomes over a 4 year period. The median patient age was
66, about three-fourths were Caucasian and almost half were
diabetic. When patients were asked to rate their level of
knowledge, about one-third reported limited or no
understanding of their chronic kidney disease and no
awareness regarding their treatment options. A significant
and substantial number of patients indicated they had no
familiarity with transplant, hemodialysis, and continuous
ambulatory or automated peritoneal dialysis. Perceived
knowledge improved with the progression of kidney
disease and frequency of nephrology visits; however,
only about half of patients with 4 or more nephrology
appointments in the prior year reported knowing of
hemodialysis, continuous ambulatory peritoneal dialysis or
transplant. Age, gender and disease had no impact on levels
of patient knowledge, but African-Americans reported
having significantly less understanding than Asians or
Caucasians. These findings suggest that the lack of
perception concerning the treatment options chronic
kidney and end stage renal disease reflects, in part, problems
with the education of patients by nephrologists and not a lack
of referral of these patients to nephrologists for care. The
discrepancy of perceived knowledge between
African-Americans and other races needs special attention.
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In 2005, in the United States, 104,000 new end-stage renal
disease (ESRD) patients initiated renal replacement therapy
with 97,143 starting hemodialysis (HD), 6875 peritoneal
dialysis (PD), and 2424 receiving a preemptive transplant.1
The importance of providing education to patients to enable
them to intelligently participate in making choices in terms
of modality selection for ESRD has been emphasized in
several recent publications.2–5 Of particular significance are
the observations that adequate chronic kidney disease (CKD)
education can delay the onset of dialysis, increase patient
choice of less costly home-based therapies, and improve
outcomes of patients after the start of dialysis.4,5
Nevertheless, there are many barriers to providing
education for the patient with CKD. The care of the patients
is complex and physician time constraints often limit the
ability to provide adequate patient education. Funding for
trained individuals to provide CKD education is often not
available. Moreover, few published studies provide guidelines
on how to provide CKD education.
In terms of modality selection when patients approach
ESRD, nephrologists have reported that patient choice is the
most important factor in choosing a dialysis therapy.6 Yet, the
majority of patients who approach ESRD do not have
adequate knowledge of the different therapeutic options.7
CRIOS, the CKD RenalSoft Informatics Observational
Study, is a prospective observational study designed to
identify trends in practice patterns and outcomes in CKD
patients. One of the goals of this study is to examine the
perceived knowledge and education of CKD patients
concerning therapeutic options for ESRD.
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RESULTS
Of the 2295 patients enrolled in the CRIOS study, 823
completed education assessment questionnaires. Of these 823
patients, clinical data and CKD stage identification were
available for 749 patients; of these, there were 676 patients
that were CKD stage 3–5. All analyses used data from these
676 patients. When comparing the patients completing the
questionnaire with those not completing the questionnaire,
the groups were the same in terms of age and percent with
diabetes; but the patients completing the questionnaire had a
slightly lower glomerular filtration rate (23.5 vs 28.7), and
had a slightly lower percent of women (42 vs 47%). Table 1
provides a summary of the demographic data on these 676
patients; 24% were stage 3, 56% stage 4, and 20% stage 5
patients.
The duration of nephrology care before entering the study
ranged from 0 to 50 years, with a mean of 5.2 years and a
median of 2 years. Patients (65%) had been seen by a
nephrologist for X1 year.
When patients were asked about their general level of
knowledge concerning their kidney disease, only 23% of
patients reported having a great deal or extensive knowledge;
35% reported having very limited or no knowledge about
their kidney disease. Their kidney disease was a source of
concern for the patients. When asked to rate their ‘worry
about their kidney disease’ over the preceding 4 weeks on a
0–10 scale (0 being not at all and 10 being extremely worried),
8% of patients were extremely worried (score of 10), 29% of
patients rated their worry as 6 or greater, and an additional
21% rated their worry as 3 or 4.
A total of 43% of patients reported having no knowledge
of HD, 57% had no knowledge of continuous ambulatory
peritoneal dialysis (CAPD), 66% had no knowledge of
automated PD, and 56% had no knowledge of transplanta-
tion (Table 2). Total 35% of patients had no knowledge of
any therapeutic modality for ESRD.
There was a significant improvement in patients’ percep-
tion of their knowledge of modalities with increased
frequency of nephrology visits in the preceding year (Table 3).
Thus, 64% of patients who had four or more visits in the
preceding year reported having knowledge of transplantation
and HD compared to only 40% (HD) and 45% (transplant)
of patients seen only once during the past year. CAPD
knowledge reportedly improved from 25 to 51% with the
increased frequency of visits.
It is of interest that as CKD stage progressed, reported
knowledge of all modalities improved significantly. Among
stage 5 patients, 70% reported knowledge of transplant, 65%
of CAPD, and 79% of HD (Table 4).
The relationship between perceived knowledge of various
ESRD therapies was then correlated with patients’ perception
of their understanding of the advantage and disadvantages of
the available treatment options (Table 5). What is striking is
that the vast majority of patients reporting no knowledge of
the various therapies indicated that they did not know about
the advantages and disadvantages of the various treatment
options. For example, 70.5% of patients reporting having no
knowledge of any ESRD therapy reported having no knowl-
edge of the advantages and disadvantages of these therapies.
The effects of gender, diabetes, race, and patient educa-
tional level on the perceived knowledge of renal replacement
therapies were then explored. Gender and diabetes had no
correlation with level of knowledge. Race, however, was
important; African-American (AA) patients had less per-
ceived knowledge of renal replacement therapies in general
(Table 5). This was particularly true for PD; 23% of AA
reported perceived knowledge of PD compared to 42% of
Caucasians and 67% of Asians (Po0.001; Table 6). Perceived
knowledge of HD was also significantly lower among AA
(34%) than for Caucasians (58%) or Asians (88%)
(P¼ 0.002). The patient educational level also had an impact
on the level of perceived knowledge concerning various
therapies. For example, patients who had a college education
reported significantly more knowledge of HD (67%)
Table 1 | Patient demographics
CKD stage
Parameter All III IV V
Age
N 676 163 381 132
Mean 65.8 64.9 66.9 63.6
s.e. 0.5 1.2 0.7 1.2
Gender
Male (%) 58.4 72.4 55.9 48.5
Female (%) 41.6 27.6 44.1 51.5
Race
Asian/Indian/Filipino (%) 2.5 3.1 2.1 3.0
Black (%) 4.3 3.7 4.2 5.3
White (%) 74.7 75.5 77.7 65.2
Other/Multiracial (%) 2.2 2.5 1.3 4.5
Missing (%) 16.3 15.3 14.7 22.0
Diabetes
Diabetic (%) 44.1 39.9 45.1 46.2
Nondiabetic (%) 55.9 60.1 54.9 53.8
GFR
N 676 163 381 132
Mean 24.1 38.8 22.2 11.5
s.e. 0.4 0.5 0.2 0.2
Primary renal disease
Diabetes 31.2 27.6 31.8 34.1
Glomerulonephritis/vasculitis/
autoimmune diseases
12.3 17.2 10.5 11.4
Interstitial nephritis/pyelonephritis 1.2 0.6 1.3 1.5
Parameter
Hypertension/largevessel/
renal vascular disease
22.5 25.2 21.0 23.5
Neoplasms/tumors 1.3 1.8 0.5 3.0
Cystic/hereditary/congenital
diseases
9.6 8.6 9.2 12.1
Miscellaneous conditions 20.4 18.4 24.1 12.1
Missing 0.6 0.0 0.5 1.5
CKD, chronic kidney disease; GFR, glomerular filtration rate.
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compared to patients with lower levels of education (53%,
P¼ 0.006).
Of the patients completing the questionnaires, 86% were
Canadian. Significantly more of the US vs Canadian patients
reported no knowledge of the various ESRD therapies
(Table 7). For example, 52% of the US patients reported no
knowledge of any ESRD therapy compared to only 33% of
Canadian patients.
DISCUSSION
The present study suggests that a large percent of CKD
patients (stage 3–5) report having limited knowledge about
their kidney disease and no knowledge of the various
therapeutic modalities for ESRD. This is surprising as the
patients had been followed by nephrology practices for a
mean of 4.8 years and a median of 2 years. More reported
knowledge was associated with increasing frequency of
nephrology visits during the preceding year and with a more
advanced stage of kidney disease. However, it is noteworthy
that perceived knowledge of peritoneal dialysis was lower
than knowledge of HD or transplant at all stages of CKD and
at all levels of frequency of nephrology visits. This suggests
that PD is either not presented to patients or is presented to
patients in a manner in which they are not able to process the
information. It appears that the delivery of information to
AAs in terms of therapeutic modalities, particularly CAPD, is
less successful than to Asians or Caucasians.
These findings are particularly important in several
respects. First, studies by Devins have suggested that
education of CKD patients can delay the onset of dialysis
and improve patient outcomes after they start dialysis.3,4
Second, studies have shown that provision of educational
programs for patients with CKD can increase the percent of
patients who will start dialysis with less expensive self-care
(including home-based therapies) as opposed to traditional,
facility-based, standard care dialysis.8 Third, it has been
shown in various chronic diseases that patient education
programs and patient knowledge can have a positive impact
on medical outcomes.9–12
The problems in providing adequate education for CKD
patients are well documented.7 It has been suggested that this
difficulty in part reflects lack of referral to nephrologists for
care.7 However, the present findings suggest that even in
patients seen by nephrologists, the levels of patient percep-
tion of knowledge about CKD and therapeutic options for
ESRD are limited. Perceived levels of knowledge improve
with increased frequency of nephrology visits and stage of
CKD. However, in patients who had four or more visits with
nephrologists in the preceding year, 35% of patients did not
report knowing about HD or transplantation and 50% about
CAPD.
Does the reported lack of knowledge actually mean that
the patients do not know about their CKD and various ESRD
therapies? It is indeed possible that the perceived lack of
knowledge may not in fact reflect actual lack of knowledge.
Therefore, the finding that the patients who did not report
knowledge also did not report understanding the advantages
and disadvantages of different therapeutic options if their
kidney disease worsened is critically important. The ability of
Table 2 | Percent of CKD patients with knowledge of various
ESRD therapies
No knowledge of HD 43%
No knowledge of CAPD 57%
No knowledge of APD 66%
No knowledge of transplantation 56%
No knowledge of any modality 35%
APD, automated peritoneal dialysis; CAPD, continuous ambulatory peritoneal
dialysis; HD, hemodialysis.
Table 3 | Frequency of nephrology visits and number of
patients with knowledge of ESRD therapies
No. of visits in preceding year
0–1 2–3 X4 P-value
Knowledge of HD 65 (40.4) 150 (58.4) 117 (64.3) o0.001
Knowledge of CAPD 39 (25.2) 111 (43.2) 91 (50.8) o0.001
Knowledge of transplant 71 (45.2) 143 (55.9) 116 (63.7) 0.003
CAPD, continuous ambulatory peritoneal dialysis; HD, hemodialysis.
Numbers in parentheses indicate percent of patients reporting knowledge.
Table 4 | Number of patients with CKD stage reporting
knowledge of ESRD therapies
CKD Stage
3 4 5 P-value
Knowledge of HD 77 (47.5) 207 (54.9) 96 (78.7) o0.001
Knowledge of CAPD 45 (28.1) 157 (42.3) 78 (65.0) 0o0.001
Knowledge of transplant 86 (53.8) 200 (53.3) 85 (69.7) 0.005
CAPD, continuous ambulatory peritoneal dialysis; CKD, chronic kidney disease; HD,
hemodialysis.
Numbers in parentheses indicate percent of patients reporting knowledge.
Table 5 | Relationship between the knowledge of various
ESRD therapeutic modalities and the understanding of the
advantages and disadvantages of these therapies
Understand advantages and disadvantages of available treatments
Understand
Therapy
Knowledge
of therapy No Yes P-value
Any therapy No 70.5 29.5 o0.0001
Yes 32.7 67.3
HD No 69.2 30.8 o0.0001
Yes 29.6 70.4
CAPD No 64.3 35.7 o0.0001
Yes 22.7 77.3
Transplant No 66.4 33.6 o0.0001
Yes 30.6 69.4
CAPD, continuous ambulatory peritoneal dialysis; HD, hemodialysis.
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patients to make informed decisions about appropriate ESRD
therapies as their CKD progresses will be compromised by
their lack of reported knowledge of the advantages and
disadvantages of the various therapies. The challenge for
nephrologists then is to better understand the barriers that
limit effective communication with patients so that the
patients’ perception of knowledge as well as their actual
knowledge of ESRD treatments improves. Patients then and
only then will be equipped and empowered to more
effectively participate in decision-making regarding their
care, such as decisions about therapeutic modalities for
ESRD.
The reasons for these perceived knowledge deficiencies are
not clear. It may reflect the difficulties in communicating
with and educating patients given the time constraints of
follow-up visits and complexity of CKD patient care. The
high level of ‘worry’ expressed by patients concerning their
CKD may pose barriers to effective communication to
patients about their disease. It is of note that patients with
at least some college education reported having higher levels
of knowledge than those with lower levels of education,
suggesting that an educational background facilitates, in
some way, patients’ ability to report understanding of their
kidney disease.
Of particular concern is the significantly greater lack of
perceived knowledge reported by AA patients, supporting the
findings of other investigators examining other chronic
diseases.13–15 Given the strikingly lower level of perceived
knowledge of AA about PD, it is possible this limits the access
of AA to this therapy. Other investigators have described
limitations in access to a variety of procedures in AA
patients.15
It is important and concerning to note that our findings
are based on predominantly Canadian patients, who
compromise 86% of the respondents to the educational
questionnaire. Not surprisingly, Canadian patients reported
more knowledge than the US patients. In Canada, in general,
the centralization of dialysis and other renal services in acute
care hospitals allows for complete integration of CKD clinics,
with home-based dialysis and in-center dialysis. Canadian
nephrologists have easier access to multidisciplinary team-
based CKD care, which includes professional services
provided by nurse educators, social workers, dieticians, and
pharmacists.16 In some provinces, funding for infrastructure
and nonmedical personnel is paid directly to the facility by
the government, whereas in others, monies from the renal
global budget are controlled by the program, which can
determine how much should be spent on pre-ESRD clinics or
on other activities. In contrast, in the United States, there is
no integration of care of patients with CKD stages 3–5 not yet
on dialysis with subsequent dialysis care. In general, CKD
care is provided by nephrologists in private office settings.
Nephrologists are paid fee for service for consultations and
follow-up care, but there is no current funding arrangement
to compensate the nephrologist or other caregivers for renal
education about treatment modalities. Access to dietary or
social work consultations for CKD patients is limited. The
importance of the recent legislation that has passed the
House of Representatives to provide funding to support CKD
patient education in the United States, therefore, deserves
special attention.
There are some limitations to the present study. The study
is a nonrandomized, cohort study of patients followed in
existing nephrology clinics. The majority of the patients
completing the questionnaire were Canadian. Only 676 of
2295 patients completed the survey questionnaire and thus
our findings may not be generalizable to the entire CKD
population. Patient education was assessed by questionnaire
with patients reporting their perceived level of knowledge.
Actual patient knowledge was not tested. Education may well
have been received but not recalled or indicated by the
patients. Future studies may well want to address the impact
of patient education programs on actual rather than
perceived knowledge.
The present study highlights that one of the challenges for
nephrologists is developing new programs or enhancing
existing ones to provide adequate education for CKD
patients. The hypothesis that lack of knowledge of CKD
patients concerning their disease reflects late referrals to
nephrologists is only a part of the problem. The lack of
effective education programs after nephrology referral
is another dimension that deserves further study and
investigation. Particular emphasis needs to be placed
Table 7 | Knowledge of various ESRD therapeutic options by
country
No knowledge of therapy
United
States (%)
Canada
(%) P-value
No knowledge of HD 70 40 o0.0001
No knowledge of CAPD 81 54 o0.0001
No knowledge of APD 87 63 0.0001
No knowledge of transplant 62 42 0.0020
No knowledge of any modality 52 33 0.0017
APD, automated peritoneal dialysis; CAPD, continuous ambulatory peritoneal
dialysis; HD, hemodialysis.
Table 6 | Number of patients by race and knowledge of ESRD therapies
Race White AA Asian Other Unknown P-value
Knowledge of HD 281 (57.5) 13 (34.2) 15 (88.2) 7 (46.7) 64 (62.7) 0.002
Knowledge of CAPD 205 (42.4) 9 (23.1) 10 (66.7) 2 (14.3) 54 (54.0) 0.001
Knowledge of transplant 276 (56.7) 17 (43.6) 12 (70.6) 10 (66.7) 56 (56.6) 0.325
CAPD, continuous ambulatory peritoneal dialysis; HD, hemodialysis.
Numbers in parentheses indicate percent of patients reporting knowledge.
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on developing educational programs for those patients
who are not able to benefit from existing programs.
Thus, the barriers to providing effective education
programs to CKD patients deserves more detailed study
and investigation, with particular emphasis on developing
educational programs for AAs and perhaps other ethnic
groups.
METHODS
From January 2003 to December 2006, 2295 patients were enrolled
in the CRIOS study; seven North American sites, which included
academic medical centers, private nephrologists offices, and
hospital-based programs in the United States and Canada,
participated. Programs were selected to participate in the study if
they had an organized CKD patient care program. The organization
of the CKD program varied from center to center. After local
research ethics board approval was obtained, subjects signed
informed consent to allow collection of clinical and laboratory
data to be entered into the software application. Participating
centers in the United States were Brigham and Women’s
Hospital, Boston, MA; Metabolism Associates, New Haven, CT;
Mid-Atlantic Nephrology Associates, Baltimore, MD; Nephrology
Associates, Birmingham, AL; in Canada, the centers were Humber
River Regional Hospital, Toronto, ON; Royal Victoria Hospital,
Montreal, QU; and Queen Elizabeth Health Science Centre,
Halifax, NS.
In its entirety, the CRIOS study was designed to collect data
on clinical care practices, selection of patients for specific
renal replacement therapy, access planning and placement,
quality of life, and the impact of patient educational interven-
tion. The data were entered into a software application, used
as a clinical management tool, at each site (RenalSoft, Baxter
Healthcare Corporation), and, on a monthly basis, patient
information was de-identified and forwarded to a central data
repository.
Patients with CKD were continuously enrolled throughout the
duration of the study. Inclusion criteria included: (1) glomerular
filtration rate o60 ml/min per 1.73 m2 (CKD stages 3–5, not on
dialysis) (2) age 18 and older, (3) ability to read and communicate
in English or French. Patients remained in the program until they
began renal replacement therapy, died, or transferred care to another
program. Information regarding demographics, health care delivery,
prescriptions, preeducational assessment, renal replacement therapy
choices, and access planning and placement information was
collected at baseline and on an ongoing basis at time of physician
or educator interaction. All data collected, other than the patient
educational assessments and patient quality of life survey, were data
that were routinely obtained during a normal clinic visit, and/or
through usual care of the patient. No additional clinic visits or
testing was required.
All enrolled patients who agreed to participate in the study were
asked to complete a self-administered survey, to determine their
knowledge of CKD and renal replacement therapies. The assess-
ments were administered while patients were receiving the standard
of care at their facility. The questions were focused on the following
areas: (1) the length of time patients were seen by a nephrologist; (2)
when patients were first told of their kidney disease, (3)
the frequency of nephrology visits, (4) patients’ understanding
of basic principles of CKD treatment options, (5) patients’
understanding of the advantages and disadvantages of available
treatments if there kidney disease worsens, (6) patients’ level of
anxiety about their CKD, and (7) patients’ interest in obtaining
further education related to kidney disease and renal replacement
therapies. The questionnaire is summarized in Appendix A. Total
86% of patients completing the questionnaire were from Canadian
centers.
Statistical methods
Tests (w2) were used to measure the strength of the association
of the knowledge of HD, PD, and kidney transplantation to
various other factors (frequency of nephrology visits in the
preceding year, CKD stage, gender, diabetic status, race, and
education level).
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No knowledge Some knowledge A great deal of knowledge
6) Hemodialysis K K K
7) Continuous ambulatory peritoneal dialysis (CAPD) K K K
8) Automated peritoneal dialysis K K K
9) Kidney transplant K K K
10) Choosing no treatment for your kidney disease K K K
11) I understand the advantages and disadvantages of available treatment
options if my kidney disease gets worse.
K Yes K No
1) In general, how would you rate your level of knowledge about your chronic kidney disease?
K I have extensive knowledge about my condition
K I have a great deal of knowledge about my condition
K I have some knowledge about my condition
K I have limited knowledge about my condition
K I have very little or no knowledge about my condition
2) When were you first told you had a problem with your kidneys?
____________ At today’s visit to the doctor OR
____________ weeks ago (enter a value between 1 and 4) OR
____________ months ago (enter a value between 1 and 12) OR
____________ one or more years ago (enter a value greater than 1)
3) When was the first time you saw a nephrologist (kidney doctor)?
____________ At today’s visit to the doctor OR
____________ weeks ago (enter a value between 1 and 4) OR
____________ months ago (enter a value between 1 and 12) OR
____________ one or more years ago (enter a value greater than 1)
4) How many times did you see your nephrologist in the past year?
____________ times(if this is you first visit, enter 0)
5) Do you know what is causing your kidney disease?
K Yes K No
In this ‘next section, please think about various options that are available for patients with kidney disease. You may or
may not have ever heard of these options. Please choose the response which most closely reflects how much knowledge
you have about each option.
Appendix A
Patient questionnaire
12) Over the past 4 weeks, how would you rate your overall stress level?
0 1 2 3 4 5 6 7 8 9 10
No stress Extremely stressed
13) Over the past 4 weeks, how would you rate how worried you are about kidney disease?
0 1 2 3 4 5 6 7 8 9 10
No worry Extremely worried
In this next section, we will be asking you to answer each question, based on the past 4 weeks, on a scale from 0 to 10.
Please circle the one answer that best describes how you have been feeling.
In this next section, we will be asking you some background questions. Please select the one answer that best describes
you.
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14) What is the highest level of education you have completed?
K No formal education
K Grade school
K Some high school
K High school
K Some college
K College
K Graduate school
15) What is your ethnic background?
K Caucasian
K African American
K Hispanic
K Asian
K Pacific Islander/Native American
K Other, please specify: _________________
16) Is your primary language something other than English?
K No K Yes, please specify: ___________________
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